European Biomedical Institute
European Biomedical Institute offers comprehensive biocompatibility testing for medical devices, specializing in ISO 10993 standards. They provide pre-clinical testing and consulting with modern laboratory facilities.
The European Biomedical Institute (EBI) is a leading provider of comprehensive biocompatibility testing and pre-clinical services for medical devices. Specializing in the ISO 10993 series, EBI offers a broad spectrum of tests, including Biological Evaluation Plans (BEP) and Reports (BER), Chemical Characterization, Cytotoxicity, Sensitization, Irritation, Material Mediated Pyrogenicity, Toxicity, Implantation, Hemocompatibility, Genotoxicity, and EO & ECH Residual Testing. EBI's state-of-the-art laboratories are among the most modern in Europe, enabling them to conduct a wide range of tests with a focus on risk management integration as per the latest ISO 10993-1:2025 revisions. They emphasize a risk-based approach, leveraging chemical characterization and minimizing animal studies where possible. Their services support the full device lifecycle, from initial planning to post-market surveillance, ensuring compliance with regulatory requirements. With a commitment to providing cost-effective solutions and expert consulting, EBI assists clients in navigating the complexities of medical device safety assessment. Their team of qualified and experienced professionals ensures that all evaluations are conducted with rigorous scientific integrity and documented traceability, aligning with ISO 14971 principles.
About
**Who they are**
European Biomedical Institute provides comprehensive biocompatibility testing for medical devices, specializing in ISO 10993 standards. They offer pre-clinical testing and consulting services.
**Expertise & scope**
* Expertise in ISO 10993-1:2025 revisions, focusing on enhanced characterization and risk logic integration with ISO 14971.
* Services include developing Biological Evaluation Plans (BEP) and Biological Evaluation Reports (BER), detailing intended use, risk assessment, chemical characterization, and test selection rationale.
* Specialized knowledge in addressing particulate risks, foreseeable misuse scenarios, and chemical characterization inputs (ISO 10993-18).
* Experience with wearable medical devices, considering unique challenges like prolonged skin contact, adhesives, and dynamic environments.
* Capabilities extend to various biocompatibility tests including Cytotoxicity, Sensitization, Irritation, Toxicity, Implantation, and Hemocompatibility.
**Reputation / proof points**
* Operates modern laboratory facilities among the most advanced in Europe.
* Emphasizes qualified authorship and peer review for biological evaluations, ensuring traceability from hazard identification to risk controls.
European Biomedical Institute provides comprehensive biocompatibility testing for medical devices, specializing in ISO 10993 standards. They offer pre-clinical testing and consulting services.
**Expertise & scope**
* Expertise in ISO 10993-1:2025 revisions, focusing on enhanced characterization and risk logic integration with ISO 14971.
* Services include developing Biological Evaluation Plans (BEP) and Biological Evaluation Reports (BER), detailing intended use, risk assessment, chemical characterization, and test selection rationale.
* Specialized knowledge in addressing particulate risks, foreseeable misuse scenarios, and chemical characterization inputs (ISO 10993-18).
* Experience with wearable medical devices, considering unique challenges like prolonged skin contact, adhesives, and dynamic environments.
* Capabilities extend to various biocompatibility tests including Cytotoxicity, Sensitization, Irritation, Toxicity, Implantation, and Hemocompatibility.
**Reputation / proof points**
* Operates modern laboratory facilities among the most advanced in Europe.
* Emphasizes qualified authorship and peer review for biological evaluations, ensuring traceability from hazard identification to risk controls.
Additional information
The European Biomedical Institute emphasizes a risk-based approach to biocompatibility, aligning with ISO 14971. Their process involves detailed Biological Evaluation Plans (BEP) that outline the strategy for demonstrating device safety, including chemical characterization and justification for test selection or waivers. The Biological Evaluation Report (BER) documents how risks were addressed. They highlight the importance of considering foreseeable misuse and post-market information, requiring evaluations to be revisited when changes could affect safety. For wearable devices, they address specific concerns such as cumulative exposure and leachables from materials like adhesives.
Key Highlights
-
Specializes in ISO 10993-1:2025 revisions, focusing on enhanced characterization and clearer risk logic.
Source
“The 2025 revision keeps biological evaluation firmly inside ISO 14971 risk management and across the full device life cycle.”
-
Offers comprehensive pre-clinical testing and consulting with modern laboratory facilities.
Source
“We offer comprehensive pre-clinical testing and consulting services of medical devices. We have our own laboratories that are among some of the most modern in all of Europe”
-
Emphasizes the integration of Biological Evaluation Plans (BEP) and Reports (BER) within the ISO 14971 risk management framework.
Source
“ISO 10993-1:2025 also formalizes the role of BEPs and BERs (Biological Evaluation Reports) as part of the risk documentation.”
-
Addresses unique biocompatibility considerations for wearable medical devices, including extended wear and material leachables.
Source
“Wearable medical devices are transforming healthcare with continuous monitoring, real-time diagnostics, and improved patient engagement. However, their design introduces distinct challenges from a biocompatibility perspective.”
Certifications & Trust Signals
-
Operates modern laboratory facilities.
Source
“We have our own laboratories that are among some of the most modern in all of Europe”
-
Emphasizes qualified authorship and peer review for biological evaluations.
Source
“Clause 9 requires that biological evaluations be “planned, conducted, and reported by competent personnel” and that the evaluation report documents the rationale for all risk decisions.”
Buyer Snapshot
Best for
- Medical device manufacturers seeking ISO 10993 compliance.
- Companies requiring detailed biocompatibility risk assessments and testing strategies.
How engagement typically works
- Consultative approach to planning and testing.
- Collaborative development of BEPs and BERs.
Typical deliverables
- Biological Evaluation Plan (BEP)
- Biological Evaluation Report (BER)
- Pre-clinical biocompatibility testing data
- Consulting on risk management integration
Good to know
- Best when requiring specialized expertise in ISO 10993-1:2025 revisions.
- Best when needing comprehensive chemical characterization and risk analysis.
HQ:
Józefów k/Otwocka, PL
Languages:
English
Timezones:
UTC+1
Claim status:
Listed
Services & Capabilities
Biocompatibility Testing (ISO 10993 Program)
Industries:
Medical Devices
Pricing model:
Custom pricing
Iso10993 Standards Supported:
ISO 10993-1, ISO 10993-18, USP <87>, USP <88>
Test Types Offered:
Cytotoxicity, Sensitization, Irritation, Systemic toxicity, Genotoxicity, Implantation, Hemocompatibility, Pyrogenicity, Other
Glp Compliant:
No
Has In House Toxicology:
Yes
Toxicology Capabilities:
Extractables and Leachables Testing, Toxicological assessments
Contact Types Supported:
Surface contact, External communicating, Implant
Duration Types Supported:
Limited (< 24h), Prolonged (24h - 30d), Permanent (> 30d)
Rush Available:
No
Nda Support:
Yes
Minimum Project Size:
No minimum
Lead Time Band:
Start in 4-8 weeks
Quote SLA:
< 24 hours
Additional biocompatibility_testing Details
Iso10993 Standards Supported
ISO 10993-1, ISO 10993-18
Test Types Offered
Cytotoxicity, Sensitization, Irritation, Material mediated pyrogenicity, Toxicity, Implantation, Hemocompatibility, Genotoxicity, EO & ECH Residual Test, Chemical Characterization
Contact Types Supported
Surface contact, External communicating, Implant
Duration Types Supported
Limited (< 24h), Prolonged (>24 h up to 30 days), Long-term (>30 days)
Lead Time Band
Start in 0-2 weeks
Quote SLA
< 24 hours
Pricing Model
Per project
